Here are the facts that activist critics of Pfizer CEO Albert Bourla are missing, according to a Yale analysis
Some misleading narratives about Bourla’s leadership that have been put forward have been distinctly unfair,' write Jeff ...
After Pfizer’s coronavirus vaccine success, CEO targeted for revenue slump
Albert Bourla, who four years ago led Pfizer through its scientific and financial triumph during the COVID-19 pandemic, is ...
Pfizer Went From Covid Star to Activist Target as Stock Fell
Pfizer Inc. and Albert Bourla got the upper hand in an early skirmish against Starboard Value LP — but the drugmaker and its ...
The Washington Post3d
After Pfizer’s coronavirus vaccine success, CEO targeted for revenue slump
Albert Bourla, who four years ago led Pfizer through its scientific and financial triumph during the covid-19 pandemic, is suddenly facing a new challenge from a large shareholder frustrated over ...
Yahoo Finance6d
Here are the facts that activist critics of Pfizer CEO Albert Bourla are missing, according to a Yale analysis
Anonymous sources have been disparagingly suggesting that Pfizer CEO Dr. Albert Bourla should be removed. After news reports suggested they initially sided with the activists, former Pfizer CEO ...
Pfizer faces showdown with $1.5 billion activist investor after post-Covid share plunge
Pfizer is facing a messy showdown this week after an outside bid to revive the company’s post-Covid share plunge took an ...
Guggenheim caught in Starboard-Pfizer crossfire
Now, despite playing no formal role in the battle between Pfizer and Starboard, Guggenheim has found itself in the crossfire of one of the messiest activist campaigns in recent Wall Street memory.
Why Pfizer Stock Tumbled by Nearly 3% on Thursday
There was some intriguing news from a Pfizer (NYSE: PFE) shareholder on Thursday that was not taken well by the market.